In vitro diagnostic reagent stability refers to the ability of an in vitro diagnostic medical device to maintain its performance characteristics within the limits specified by the manufacturer, reflecting the product's ability to grow with In the process of storage, transportation and use of in vitro diagnostic reagents, various influencing factors such as temperature, humidity, light, repe...
Chemiluminescence immunoassay technology has long been well-known in the field of in vitro diagnostics! These include, direct chemiluminescence, electrochemiluminescence, enzymatic chemiluminescence, indirect chemiluminescence. So many types of luminescence use luminescent agents that are also very different!1. Acridine ester Direct chemiluminescence Acridine ester (AE) is a tricyclic organic...
Major risk factors for cardiovascular disease Hypertension: one of the main controllable risk factors, accounting for 50% of cardiovascular disease morbidity and 20% of deaths, but the awareness rate is only 46.9%, and the blood pressure control rate is even lower to 15.3%. Dyslipidemia: Studies have shown that the awareness, treatment and control rates of dyslipidemia in ≥ 18-year-olds need to...
World Stroke Day is observed on October 29 to underscore the serious nature and high rates of stroke, raise awareness of the prevention and treatment of the condition, and ensure better care and support for survivors. Stroke and platelet function Stroke refers to an acute cerebrovascular disease caused by the sudden rupture of blood vessels in the brain or the sudden interruption of blood flo...
WBC, CRP, and PCT test indicators for judging infection, and they can be elevated to varying degrees when infection occurs, but they are often inconsistent in clinical work, so how should we analyse these inconsistent results? 1. Blood routine WBC and neutrophil ratio can be used to distinguish bacterial infections from non-bacterial infections, but it should be noted that the sensitivity and spec...
Introduction: In the rapidly evolving field of diagnostics, advanced technologies are paving the way for faster, more accurate, and convenient testing solutions. As a leading manufacturer and exporter of dry-chemistry chemiluminescence immunoassay analyzers and assay kits, we are proud to introduce a breakthrough solution that addresses the key challenges in diagnostic testing. Our cutting-edge pl...
In the fast-evolving landscape of healthcare, Point-of-Care Testing (POCT) has emerged as a game-changer. This innovative approach allows healthcare providers to conduct tests at or near the site of patient care, leading to quicker diagnosis and treatment. One of the standout advantages of POCT is its ability to streamline processes, offering numerous benefits that enhance patient care and operati...
In the realm of laboratory testing, the evolution from Fluorescence Immunoassay (FIA) to Chemiluminescence Immunoassay (CLIA) represents a significant advancement. This transition not only enhances the accuracy of test results but also transforms the efficiency of testing processes in healthcare settings. As labs seek to improve their diagnostic capabilities, understanding the benefits of upgradin...